Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION
Report ID | 146880 |
Drug Identification Number | 02327813 |
Brand name | GALLIUM (GA67) CITRATE INJECTION |
Common or Proper name | Gallium (Ga 67) Citrate injection |
Company Name | CURIUM CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GALLIUM CITRATE GA 67 |
Strength(s) | 74MBq |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 6 & 12 mCi |
ATC code | V09HX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-08 |
Actual start date | 2021-10-08 |
Estimated end date | 2021-10-15 |
Actual end date | 2021-10-15 |
Shortage status | Resolved |
Updated date | 2021-10-19 |
Company comments | The most recent lot of Gallium Citrate Ga 67 Injection is outside our specifications for release. As a result, product will not be available for shipment Oct 8-14, 2021. The next lot is scheduled to release on Friday, Oct. 15. We apologize for an inconvenience caused by this issue. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-10-07 | English | Compare |
v2 | 2021-10-07 | French | Compare |
v3 | 2021-10-09 | English | Compare |
v4 | 2021-10-19 | English | Compare |
v5 | 2021-10-19 | French | Compare |
Showing 1 to 5 of 5